Fig. 2. Cumulative incidence of chronic GvHD moderate/severe after alloSCT for ALL patients treated with ATLG or PTCy.
Comparison of cumulative incidence of moderate and severe cGvHD over a 3-year period in ALL patients treated with ATLG or PTCy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.